Literature DB >> 16699256

Characteristics of multiple primary malignancies associated with lung cancer by gender.

Shuji Haraguchi1, Masafumi Hioki, Kiyoshi Koizumi, Takao Hisayoshi, Tomomi Hirata, Hirohiko Akiyama, Kyoji Hirai, Iwao Mikami, Hirotoshi Kubokura, Kazuo Shimizu.   

Abstract

BACKGROUND: There are gender differences in multiple primary malignancies associated with lung cancer (MPMLC) in terms of clinical characteristics. However, the importance of these differences in the management of patients has not been clarified.
OBJECTIVE: Differences in characteristics affected by gender were investigated in MPMLC to identify factors important for the proper management of the patients.
METHODS: Univariate and multivariate analyses were performed between 82 male and 34 female patients with MPMLC treated from August 1982 to March 2002.
RESULTS: In univariate analysis, the numbers of smokers or ex-smokers, smoking-related cancer and synchronous multiple primary malignancies were significantly increased in males with MPMLC (p < 0.0001, p < 0.05 and p < 0.05, respectively). In multivariate analysis, synchronous multiple primary malignancies and the number of smokers or ex-smokers were significantly different between male and female MPMLC. Gastric, lung and colon cancers were major constituents in male MPMLC, and 40.2% of all malignancies were smoking-related cancers. On the other hand, breast and uterine cancers were major constituents in female MPMLC, and only 20.6% of all MPMLC were smoking-related cancers.
CONCLUSIONS: Male patients with MPMLC demonstrated significant smoking history and synchronous multiple primary malignancies, indicating the need for different approaches to properly manage and follow up male versus female MPMLC patients.

Entities:  

Mesh:

Year:  2006        PMID: 16699256     DOI: 10.1159/000093324

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  5 in total

1.  Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.

Authors:  Martin Faehling; Birgit Schwenk; Sebastian Kramberg; Sabine Fallscheer; Matthias Leschke; Jörn Sträter; Robert Eckert
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-30       Impact factor: 4.553

2.  Prevalence of lung tumors in patients with esophageal squamous cell carcinoma and vice versa: a systematic review and meta-analysis.

Authors:  Laurelle van Tilburg; Steffi E M van de Ven; Manon C W Spaander; Laurens A van Kleef; Robin Cornelissen; Marco J Bruno; Arjun D Koch
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-23       Impact factor: 4.553

3.  Hereditary factors in multiple primary malignancies associated with lung cancer.

Authors:  Shuji Haraguchi; Kiyoshi Koizumi; Masafumi Hioki; Takao Hisayoshi; Tomomi Hirata; Kazuo Shimizu
Journal:  Surg Today       Date:  2007-04-30       Impact factor: 2.549

4.  Patients with a Previous History of Malignancy Undergoing Lung Cancer Screening: Clinical Characteristics and Radiologic Findings.

Authors:  Darragh F Halpenny; Jane D Cunningham; Niamh M Long; Ramon E Sosa; Michelle S Ginsberg
Journal:  J Thorac Oncol       Date:  2016-05-17       Impact factor: 15.609

5.  The CT delta-radiomics based machine learning approach in evaluating multiple primary lung adenocarcinoma.

Authors:  Yanqing Ma; Jie Li; Xiren Xu; Yang Zhang; Yi Lin
Journal:  BMC Cancer       Date:  2022-09-03       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.